About
- About Avecho
- Board & Leadership
TPM^® Technology
Portfolio
Invest
- Investor Centre
- Media Centre
Contact

Hit enter to search or ESC to close

ProPhase Arbitration Ruling Handed Down

November 16, 2016

Click here to read more

Post navigation

Phosphagenics Extends Due Diligence Period for Opioid Patches in Japan

Reformulation of Phosphagenics Transdermal TPM/Oxymorphone Patch Complete

Related Posts

TPM® Enhances Cannabinoid Bioavailability in Comparative Canine Study

September 19, 2022September 19, 2022

Phosphagenics Receives Further Arbitration Process Update

October 23, 2018

Phosphagenics Announces Successful Results from its Phase 2 TPM®/Tretinoin Gel Study on Acne Patients

October 7, 2014

Recent Posts

Media | Avecho featured on 9 News
June 23, 2025
New Sites Commence Recruitment For Phase III Clinical Trial
May 20, 2025
Avecho receives US$3M upfront payment from Sandoz AG
March 28, 2025

Categories

Analyst Coverage
Company Announcement
Company Report
Investor Webinar
Media Coverage
Newsletter
Press Release
Uncategorised

About us

We see a future where more patients can get even more from their treatments through innovative delivery technologies.

Stay Posted

Stay informed about our latest news and developments.

Leave this field empty if you're human:

About Avecho

TPM^® Technology

Portfolio

Investor Centre
- Investor Centre
- Media Centre

© Copyright 2019 Avecho Biotechnology Ltd.